parkinsons

Roche to advance prasinezumab into Phase III development for early-stage Parkinson’s disease

Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage…

3 weeks ago

Golfers swing into action for the Chilterns Neuro Centre

Wednesday 11 June, 2025 The Chilterns Neuro Centre is delighted by the success of its Charity Golf Day, held at…

3 weeks ago